BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26106647)

  • 1. Bisphosphonates: Clinical Applications and Adverse Events in Dentistry.
    Polymeri AA; Kodovazenitis GJ; Polymeris AD; Komboli M
    Oral Health Prev Dent; 2015; 13(4):289-99. PubMed ID: 26106647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Shudo A; Kishimoto H; Takaoka K; Noguchi K
    Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaws.
    Kushner GM; Alpert B
    Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaw: what we have learned.
    Tabari E; Sikavi C
    Alpha Omegan; 2014; 107(2):8-15. PubMed ID: 25269218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The rare case of osteonecrosis of the jaws in a patient treated with bisphosphonates for osteoporosis].
    Lewandowski B; Brodowski R; Kość T; Migut M; Wojnar J
    Przegl Lek; 2016; 73(1):46-8. PubMed ID: 27120948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate and Implant Dentistry - Is it Safe?
    Thirunavukarasu A; Pinto HG; Seymour KG
    Prim Dent J; 2015 Aug; 4(3):30-3. PubMed ID: 26556516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisphosphonate-related osteonecrosis of the jaw].
    Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
    Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
    Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates and their clinical implications in endodontic therapy.
    Moinzadeh AT; Shemesh H; Neirynck NA; Aubert C; Wesselink PR
    Int Endod J; 2013 May; 46(5):391-8. PubMed ID: 23137312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
    López-Cedrún JL; Sanromán JF; García A; Peñarrocha M; Feijoo JF; Limeres J; Diz P
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):874-9. PubMed ID: 23866309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk assessment of bisphosphonate-related osteonecrosis of the jaw based on CBCT scans].
    Koppány F; Joób-Fancsaly Á; Németh Z; Belik AA; Vaszilkó M; Varmuzsa EM; Csomó KB
    Orv Hetil; 2020 May; 161(21):867-872. PubMed ID: 32427571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bisphosphonate-related osteonecrosis of the jaws].
    Sogacheva VV; Syomkin VA
    Stomatologiia (Mosk); 2022; 101(6):85-90. PubMed ID: 36562373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.